MAPK8 and breast cancer: pointed out that trichlorobendazole triggered GSDME-dependent pyroptosis of breast cancer cells and clarified the involved mechanism was associated with augment of ROS/JNK/Bax-mitochondrial signal, suggesting the potential therapeutic use of this drug for treating breast cancer patients with high GSDME expression (37).